Royal Fund Management, LLC

Position in ABBV — AbbVie Inc.

CIK 1810099 Lady Lake, FL

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$12,790,357

+$2,516,565 QoQ

Shares Held

50,828

+7.6% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.73%

of 13F equity value

Holder Rank

#795

of 4,153 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2026

CallValue

$1,154

CallShares

600

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Royal Fund Management, LLC holds $53,687,214 across 9 Drug Manufacturers - General names. ABBV ranks #1 (23.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	50,828	$12,790,357
2	JNJ	Johnson & Johnson	37,731	$9,582,542
3	MRK	Merck & Co., Inc.	71,225	$9,152,412
4	AMGN	Amgen Inc	22,196	$8,037,615
5	LLY	ELI LILLY & Co	5,141	$6,166,270
6	BMY	Bristol Myers Squibb Co	67,139	$3,868,549
7	GSK	GSK plc	36,119	$1,893,357
8	PFE	Pfizer Inc	77,701	$1,871,040

All Filings in ABBV

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,790,357	50,828	+7.6%	Shares	Sole	2026-07-20
2026-03-31	$1,154	600	+14900.0%	Call	Sole	2026-05-19
2026-03-31	$10,273,792	47,238	+7.0%	Shares	Sole	2026-05-19
2025-12-31	$913	4	-50.0%	Call	Sole	2026-01-15
2025-12-31	$10,085,777	44,141	+29.5%	Shares	Sole	2026-01-15
2025-09-30	$7,890,188	34,077	-26.2%	Shares	Sole	2025-10-29
2025-09-30	$1,852	8	-99.0%	Call	Sole	2025-10-29
2025-06-30	$8,568,961	46,164	+7.4%	Shares	Sole	2025-08-13
2025-06-30	$148,496	800	-20.0%	Call	Sole	2025-08-13
2025-03-31	$9,009,150	42,999	-3.5%	Shares	Sole	2025-05-14
2025-03-31	$209,520	1,000	-54.5%	Call	Sole	2025-05-14
2024-12-31	$7,914,580	44,539	-9.0%	Shares	Sole	2025-01-16
2024-09-30	$9,668,028	48,957	+4.9%	Shares	Sole	2024-10-08
2024-09-30	$434,456	2,200	-8.3%	Call	Sole	2024-10-08
2024-06-30	$8,003,980	46,665	-1.3%	Shares	Sole	2024-07-18
2024-03-31	$437,040	2,400	-17.2%	Call	Sole	2024-04-11
2024-03-31	$8,613,876	47,303	-1.3%	Shares	Sole	2024-04-11
2023-12-31	$7,423,992	47,906	-0.4%	Shares	Sole	2024-02-06
2023-12-31	$449,413	2,900	-12.1%	Call	Sole	2024-02-06
2023-09-30	$7,170,531	48,105	-2.7%	Shares	Sole	2023-10-17
2023-06-30	$6,659,838	49,431	+8.8%	Shares	Sole	2023-07-12
2023-06-30	$444,609	3,300	-5.7%	Call	Sole	2023-07-12
2023-03-31	$7,239,541	45,426	+7.0%	Shares	Sole	2023-04-10
2023-03-31	$557,795	3,500	-16.7%	Call	Sole	2023-04-10
2022-12-31	$678,762	4,200	+7.7%	Call	Sole	2023-01-20
2022-12-31	$6,861,798	42,459	+8.5%	Shares	Sole	2023-01-20
2022-09-30	$5,251,905	39,132	-5.0%	Shares	Sole	2022-11-14
2022-06-30	$6,311,110	41,206	+4.8%	Shares	Sole	2022-07-28
2022-03-31	$632,229	3,900	—	Call	Sole	2022-05-13
2022-03-31	$6,372,868	39,312	-2.4%	Shares	Sole	2022-05-13
2021-12-31	$5,455,672	40,293	+1.2%	Shares	Sole	2022-02-11
2021-09-30	$4,292,794	39,796	+1.9%	Shares	Sole	2021-10-20
2021-06-30	$4,400,619	39,068	-2.1%	Shares	Sole	2021-07-26
2021-03-31	$4,318,735	39,907	+4.3%	Shares	Sole	2021-04-29
2020-12-31	$4,101,487	38,278	-5.9%	Shares	Sole	2021-02-02
2020-09-30	$3,563,599	40,685	-10.0%	Shares	Sole	2020-10-13
2020-06-30	$4,437,834	45,201	+24.2%	Shares	Sole	2020-08-06
2020-03-31	$2,773,773	36,406	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.